NCT07217873 - IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

October 31, 2027

Conditions

Scoliosis CorrectionIron DeficiencyTransfusion BloodSurgery ComplicationsSpinal FusionScoliosis Idiopathic AdolescentScoliosis Neuromuscular

Interventions

DRUG

Ferric carboxymaltose IV

Ferric carboxymaltose is an intravenous treatment for iron deficiency.

DRUG

Normal Saline (Placebo)

Normal saline is the recommended diluent for ferric carboxymaltose, and on its own serves as the placebo control for this study.

Trial Locations (1)

Columbia University Irving Medical Center, New York

All Listed Sponsors

collaborator

Association for the Advancement of Blood & Biotherapies

UNKNOWN

lead

Columbia University

OTHER